Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jaguar Animal Health

8.06
+1.3920.84%
Post-market: 7.95-0.1052-1.31%19:37 EDT
Volume:59.66K
Turnover:469.46K
Market Cap:5.43M
PE:-0.06
High:8.61
Open:6.78
Low:6.78
Close:6.67
Loading ...

Proof-of-Concept Data for Rare Disease Indications MVID and SBS-IF for Jaguar Health's Crofelemer to be Presented at April 2025 ELITE PED-GI Congress

ACCESS Newswire
·
17 Apr

Jaguar Health to present results from OnTarget study in breast cancer patients

TipRanks
·
16 Apr

Jaguar Health files to sell 1.29M shares of common stock for holders

TIPRANKS
·
16 Apr

Jaguar Health Announces Significant Results in Breast Cancer Patients Accepted for Presentation at Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting

ACCESS Newswire
·
15 Apr

Jaguar Animal Health trading halted, volatility trading pause

TIPRANKS
·
11 Apr

Napo Pharmaceuticals, a Jaguar Health Family Company, Exhibiting at the Oncology Nursing Society (ONS) Congress for the FDA-Approved Gelclair Oral Mucositis Prescription Product

ACCESS Newswire
·
08 Apr

Jaguar Animal Health Secures $3.448M in Private Placement

TIPRANKS
·
05 Apr

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ACCESS Newswire
·
05 Apr

Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules

ACCESS Newswire
·
02 Apr

Jaguar Health Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
01 Apr

Jaguar Health Reports 2024 Financials: 2024 Net Revenue Up Approximately 20% Over 2023

ACCESS Newswire
·
31 Mar

83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey

ACCESS Newswire
·
28 Mar

Jaguar Health Inc expected to post a loss of $18.50 a share - Earnings Preview

Reuters
·
28 Mar

Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study

ACCESS Newswire
·
27 Mar

Sector Update: Health Care Stocks Retreat Wednesday Afternoon

MT Newswires Live
·
27 Mar

Jaguar Health Presenting March 27 at Emerging Growth Conference and Holding Investor Webcast March 31 Regarding Q4 2024 Financials & Near-Term Catalysts

ACCESS Newswire
·
26 Mar

Jaguar Health Executives Invest in $3.5 Million Bridge Financing; Shares Fall

MT Newswires Live
·
26 Mar

Jaguar Health CEO, board members, investors invest in $3.448M bridge financing

TIPRANKS
·
26 Mar

Jaguar Health CEO, Board Members, Other C-Suite Members, and Institutional and Accredited Investors Invest in $3.448 Million Bridge Financing Priced At-The-Market Under Nasdaq Rules

ACCESS Newswire
·
26 Mar

Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now

GlobeNewswire
·
26 Mar